Pharmaceutical New Dynamics Inc is categorized under Pharmaceutical Machinery Manufacturers in , and active since 1995.
Pharmaceutical New Dynamics Inc was established in 1995, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Pharmaceutical Machinery Manufacturers business, which does work in the B2B market, and is classified as a Pharmaceutical Machinery Manufacturers, under code number 333249 by the NAICS.
If you are seeking more information, feel free to contact Noel Davila at the company’s single location by writing to 954 Avenue Ponce De Leon Apartment, , 00907 or by phoning (787) 725-0834. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Pharmaceutical New Dynamics Inc |
Contact Person: | Noel Davila |
Address: | 954 Avenue Ponce De Leon Apartment, , 00907 |
Phone Number: | (787) 725-0834 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1995 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Pharmaceutical Machinery Manufacturers |
SIC Code: | 3559 |
NAICS Code: | 333249 |
Share This Business: |
Pharmaceutical New Dynamics Inc was started in 1995 to provide professional Pharmaceutical Machinery Manufacturers under the SIC code 3559 and NAICS code 333249. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Noel Davila for inquiries that concern Pharmaceutical New Dynamics Inc by calling the company number (787) 725-0834, as your correspondence is most welcome. Additionally, the physical location of the single location of Pharmaceutical New Dynamics Inc can be found at the coordinates as well as the street address 954 Avenue Ponce De Leon Apartment in , 00907.
For its online presence, you may visit Pharmaceutical New Dynamics Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.